Latest 10-Q quarterly reports

M-tron Industries, Inc. announced a 13.8% increase in Q2 2026 revenue and a substantial rise in cash and cash equivalents, driven by strong performance in aerospace, defense, and avionics sectors.

Nauticus Robotics, Inc. filed its Q2 2026 Form 10-Q, revealing a 57% year-over-year revenue decrease to $885,947 and a net loss of $11.1 million, while highlighting progress in strategic initiatives and ongoing liquidity concerns.

Ares Real Estate Income Trust Inc. announced its Q2 2026 financial results, showing growth in rental revenues and net asset value, alongside strategic property acquisitions and a reduced leverage ratio.

New Peoples Bankshares, Inc. announced a significant increase in net income and net interest income for the second quarter of 2026, driven by loan growth and improved net interest margin.

iAnthus Capital Holdings, Inc. filed its Q2 2026 10-Q, revealing ongoing net losses and a substantial working capital deficit, though it highlights strategic segment realignments and a new revolving credit line.

BioStem Technologies' Q2 2026 Form 10-Q reveals a significant revenue decrease and increased operating costs, leading to a substantial net loss, though offset by a strategic acquisition and ongoing financing efforts.

The 21Shares Solana ETF (TSOL) reported a significant decrease in net assets and Solana holdings for the second quarter of 2026, driven by a substantial drop in SOL's market price and increased share redemptions.

InterPrivate Investment Partners V, Inc. (IPVV) has filed its Q2 2026 Form 10-Q, detailing its post-IPO financial status and operational setup, with substantial funds held in trust for a future business combination.

Azitra, Inc. files its Q2 2026 10-Q, detailing continued operational losses and efforts to regain NYSE listing compliance, alongside significant financing activities.

Reviva Pharmaceuticals Holdings, Inc. reported its Q2 2026 results, highlighting continued net losses, a Nasdaq delisting, and a move to the OTCQB Venture Market, while advancing its brilaroxazine development program.

BitGo Holdings, Inc. (BTGO) reported a net loss of $19.0 million for the second quarter of 2026, a significant shift from a net income of $38.3 million in the prior year, alongside a substantial increase in digital asset sales revenue.

Blue Water Acquisition Corp. III files its Q2 2026 10-Q, reporting on its status as a SPAC with no operating revenue and detailing its ongoing search for a business combination, alongside a material weakness in internal controls.

Turn Therapeutics Inc. reports substantial net losses and an accumulated deficit, raising concerns about its going concern status, while advancing its GX-03 drug candidate.

Holistic Asset Finance Group Co., Ltd. announced a significant 450% increase in revenue for the second quarter of 2026, driven by expansion in marketing services and new product sales, though net losses persist.

Ashford Hospitality Trust's Q2 2026 filing reveals a net income of $128.0 million, but highlights significant debt maturities and ongoing going concern issues.

Evolution Global Acquisition Corp files its Q2 2026 quarterly report, detailing its financial status and progress towards a business combination.

Virgin Galactic's Q2 2026 report reveals significant operating losses and substantial doubt about its ability to continue as a going concern, despite progress in debt reduction and future revenue backlog.

U.S. GoldMining Inc. reported a substantial increase in net loss for the six months ended June 30, 2026, driven by heightened exploration and administrative expenses, while continuing to rely on equity financing.

Mexco Energy Corporation announced a substantial increase in net income for the second quarter of 2026, driven by higher oil prices and successful acquisitions, alongside planned capital expenditures.

Soulpower Acquisition Corporation files its Q2 2026 10-Q, detailing progress on its business combination with SWB LLC and providing an update on its financial condition, including significant trust account balances and ongoing operational expenses.

Atea Pharmaceuticals reported its Q2 2026 financial results, highlighting progress in its HCV and HEV programs, with topline results from the C-FORWARD Phase 3 trial anticipated in early Q1 2027.

FinWise Bancorp reported a decrease in net income for the second quarter of 2026 compared to the prior year, primarily driven by a substantial increase in the provision for credit losses.

Crown Reserve Acquisition Corp. I reports on its Q2 2026 financial status, highlighting progress on its business combination with Carvix, Inc., while noting ongoing operational funding reliance on its sponsor.

Crown Crafts Inc. announced a significant turnaround in net income for the three-month period ended June 28, 2026, driven by a substantial tariff refund and increased sales in its bibs, toys, and disposable products segment.

American Exceptionalism Acquisition Corp. A reports net income of $2.82 million for Q2 2026, primarily from interest on trust account investments, while continuing its search for a business combination.

Sizzle Acquisition Corp. II files its Q2 2026 Form 10-Q, detailing financial status and progress towards its business combination with Trasteel.

Resideo Technologies announced Q2 2026 results with revenue up 2.0% to $1.98 billion and improved gross margins, while navigating the significant strategic separation of its ADI Global Distribution business.

Journey Medical Corporation's Q2 2026 results show a 23% total revenue increase driven by Emrosi, though net losses persist, raising going concern questions.

Battalion Oil Corporation filed its Form 10-Q for the quarter ended June 30, 2026, detailing a net loss, significant debt refinancing, and ongoing capital raise efforts.

Power REIT's Q2 2026 Form 10-Q reveals a net loss attributable to common shareholders of $784,138 for the first six months, alongside a significant accumulated deficit, while also detailing asset sales and a reverse stock split.